Chemistry Letters 2002
267
Table 1. Resolution of 2-arylalkanoic Acids by (1S, 3S)-1a
columnar hydrogen-bond network, as were found in less-soluble
diastereomeric salts of our previous studies (Figure 1a).1;2 The
þ
ꢁ
remarkable point is the role of the hydroxy group of 1a H in the
hydrogen-bond network. In this structure, the hydroxy group of
1aꢁHþ directly forms hydrogen-bonds with the carboxylate
oxygen, resulting in the formation of an infinite sheet of
hydrogen-bonds in the less-soluble salt (Figure 1b). This sheet
structure is reinforced by hydrogen-bonds with water molecules
incorporated in the less-soluble salt. As a result, a quite stable
hydrogen-bond sheet is realized in the less-soluble salt. This is the
first example of a less-soluble salt, in which the hydroxy group of
an amino alcohol directly interacts with a columnar structure,
made by ammonium hydrogens and carboxylate oxygens, to form
a hydrogen-bond sheet.
Although the resolution ability of this amino alcohol is not
high enough for practical use, the crystal structure of the less-
soluble salts shows that the geometrical relationship between the
hydroxy group and the amino group is very important for the
formation of a stable hydrogen-bond sheet. Thus, it is expected
that this structure would become a potential candidate for a novel
basic resolving agent; upon introducing a suitable substituent on
the aromatic group of 1a to realize close packing of less-soluble
diastereomeric salts, a morepowerful basic resolving agentwould
be achieved.
by the X-ray crystallographic analysis of (1S, 3S)-1aꢁðÀÞ-
ditoluoyltartrate.6
Concerning 1b, its enantiopure form was difficult to be
obtained by the diastereomeric resolution. Instead, chiral HPLC
was found to be effective for the separation of the enantiomers.7
The resolution of 2-arylalkanoic acids was performed using
enantiopure 1a as a resolving agent (Table 1). As a result, it was
found that the resulting diastereomeric salts had rather high
solubility in aqueous alcohol and that the efficiency of resolution
was quite low when the aryl group was a substituted phenyl group.
In contrast, moderate efficiency of resolution could be achieved in
the cases of 2-arylalkanoic acids having a naphthalene ring at the
ꢀ-position.
Dedicated to Prof. Teruaki Mukaiyama on occasion of his
75th birthday.
References and Notes
1
K. Kinbara, Y. Harada, and K. Saigo, J. Chem. Soc., Perkin Trans. 2,
2000, 1339; K. Kinbara, K. Oishi, Y. Harada, and K. Saigo,
Tetrahedron, 56, 6651 (2000).
K. Kinbara, K. Sakai, Y. Hashimoto, H. Nohira, and K. Saigo, J. Chem.
Soc., Perkin Trans. 2, 1996, 2615.
K. Kinbara, Y. Kobayashi, and K. Saigo, J. Chem. Soc., Perkin Trans. 2,
2000, 111; K. Kinbara, Y. Kobayashi, and K. Saigo, J. Chem. Soc.,
Perkin Trans. 2, 1998, 1767.
The crystal structure of the less-soluble salt of (1S, 3S)-
8
ꢁ
1a ðSÞ-naproxen (entry 2) is shown in Figure 1. This crystal has a
quite characteristic hydrogen-bonding pattern, compared with
otherþreported examples.1{3 At first, the ammonium hydrogen of
1aꢁH and the carboxylate oxygen of a naproxen anion form a
2
3
4
5
P. Kuehne, A. Linden, and M. Hesse, Helv. Chim. Acta, 79, 1085 (1996).
(1S, 3S)-1a: mp 113.5–114 ꢂC; 1H NMR (CDCl3) ꢂ ¼ 1:58 (br, s, 3H),
2.06(dt, 1H, J ¼ 6:3, 13.7 Hz), 2.46(ddd, J ¼ 3:0, 6.3, 13.7 Hz), 4.64(t,
1H, J ¼ 6:3 Hz), 5.34 (dd, 1H, J ¼ 3:0, 6.3 Hz), 7.31–7.43 ppm (m, 4H);
IR (KBr) 3350, 3300, 3125, 2925, 2700, 1650, 1320, 1300, 1040, 990,
17:2
770 cmÀ1; ½ꢀꢃ
¼ 38:1 (c ¼ 1:00, EtOH). (1R, 3R)-1a: mp 112–
D
17:2
113.5 ꢂC; ½ꢀꢃ
¼ À39:3 (c ¼ 1:00, EtOH); 1H NMR and IR spectra
D
were identical with (1S, 3S)-1a.
Crystal data for (1S, 2S)-1aꢁðÀÞ-ditoluoyl-L-tartrate: C29H29NO9,
6
7
ꢀ
M ¼ 535:55, Orthorhombic, space group P21212, a ¼ 14:994ð1Þ A,
ꢀ
ꢀ
ꢀ 3
b ¼ 24:595ð2Þ A, c ¼ 7:927ð2Þ A, V ¼ 2923:3ð3Þ A , Z ¼ 4, Dc ¼
1:217 Mg mÀ3, R ¼ 0:085, reflections used ¼ 3970. The details of the
refinement was submitted as supporting information.
Daicel CrownPak CRþ (eluent: pH1.9 HClO4Þ was used for the
separation of the enantiomers. A small amount of unknown compound
cotaminates (þ)-1b. The details for the separation and characterization
of (þ)- and (À)-1b will be reported elsewhere. (þ)-1b: The first
fraction; Colorless oil; 1H NMR (CDCl3) ꢂ ¼ 1:64 (dt, 1H, J ¼ 6:0,
13.2 Hz), 2.13 (br, s, 3H), 2.81 (dt, J ¼ 6:6, 14.1 Hz), 4.24 (t, 1H,
J ¼ 6:6 Hz), 5.05 (t, 1H, J ¼ 6:0 Hz), 7.30–7.44 ppm (m, 4H); IR (KBr)
3350, 2950, 1580, 1460, 1340, 1040, 770, 740 cmÀ1; CD (CHCl3,
7:2 ꢄ 10À4 M, 1.0 cm): ꢃðꢁ"Þ ¼ 280 (1.5). (À)-1b: The second
fraction; Colorless oil; CD (CHCl3, 7:2 ꢄ 10À4 M, 1.0 cm):
ꢃðꢁ"Þ ¼ 280 (0.23); 1H NMR and IR spectra were identical with
(þ)-1b.
8
Crystal data for (1S, 2S)-1aꢁðSÞ-naproxen: Space group, C2,
ꢀ
ꢀ
ꢀ
Figure 1. Crystal structure of less-soluble (1S, 3S)-1aꢁðSÞ-
naproxen. a) Schematic representation of the hydrogen-bond
column. b) Hydrogen-bond sheet viewed down the b-axis. The
dotted lines represent hydrogen bonds.
a ¼ 20:516ð5Þ (A), b ¼ 6:263ð1Þ (A), c ¼ 19:027ð4Þ (A), ꢁ ¼
119:73ð1Þ ( ), V ¼ 2123:0ð7Þ A , Z ¼ 2, Dc ¼ 1:272 Mg mÀ3, R ¼
0:052, reflections used ¼ 2735. The detail of the refinement was
submitted as supporting information.
ꢂ
ꢀ 3